December 14, 2009 (San Antonio, Texas) — New results coming from 2 mature trials with exemestane (Aromasin, Pfizer) suggest that this aromatase inhibitor differs slightly from the other 2 available ...
BERLIN — New data from the SOFT and TEXT trials showed that women with premenopausal invasive lobular carcinoma, than those with invasive ductal carcinoma, experience a greater magnitude of benefit ...
Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resection for Ductal Carcinoma In Situ of the Breast A randomized phase II study was conducted in ...
Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial In the study, 7,576 ...
Adjuvant breast cancer treatments often act by reducing circulating estrogen levels or inhibiting estrogen receptor action. Preclinical studies have suggested that exemestane, which acts by ...
Review the side-effects of Exemestane as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Switching to exemestane after two to three years of tamoxifen treatment improved overall survival in patients with estrogen-sensitive breast cancer, according to results from the Intergroup Exemestane ...
Learn everything you need to know about Exemestane-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback